A Randomized, Multi-Center Study to Compare the Effects of CRx-401 to Bezafibrate Plus Placebo on Plasma Glucose Levels When Given to Subjects With Type II Diabetes on Metformin.
Phase of Trial: Phase II
Latest Information Update: 28 May 2009
At a glance
- Drugs Bezafibrate; Bezafibrate/diflunisal
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 May 2009 Actual patient number (120) added, as reported in a media release from CombinatoRx.
- 28 May 2009 Primary endpoint 'Fasting glucose level' has been met.
- 15 May 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History